Business
Branded Legacy and Novus Partner to Develop Plant-Based Meds for Health Plans
Branded Legacy and Novus Partner to Develop Plant-Based Meds for Health Plans.
About this update from Novus Acquisition & Development Corp.
[{"type":"text","content":"\n\n\n\nBranded Legacy and Novus Partner to Develop Plant-Based Meds for Health Plans\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nBranded Legacy and Novus Partner to Develop Plant-Based Meds for Health Plans\nPR Newswire\nMELBOURNE, Fla, Sept. 12, 2023\n\n\n\nBranded Legacy and Novus Partner to Develop Plant-Based Meds for Health Plans\nMELBOURNE, Fla, Sept. 12, 2023 /PRNewswire/ -- Branded Legacy, Inc (OTC.PK: BLEG), an emerging biotechnology company, is excited to announce a strategic partnership with Novus Acquisition & Development Corp (OTC.PK: NDEV), a national supplemental health insurance carrier that is a pioneer in offering cannabis-embedded health plans for both recreational and medical use. This collaboration marks a significant milestone in Branded Legacy's mission to revolutionize the biotechnology landscape while creating a profound impact on the healthcare industry.\nThe collaboration will entail Novus's expansive distribution network of dispensaries across the United States. It will serve as a distributor, promoting Branded Legacy's formularies to their policyholders and those within health carriers that incorporate Novus benefit packages.\nThe deal will entail the following:\nPoint of Sale Integration: Novus will seamlessly integrate Legacy Brands' formularies into dispensaries and healthcare facilities'. This ensures policyholders can easily access Legacy's prescriptions when visiting these locations.\nDual Role as Pharmacy Benefits Manager and Health Carrier: Making Novus a key player in distributing Legacy's formularies to policyholders at the point of sale and wholesale level. This partnership has the potential to enhance the availability and affordability of proprietary cannabis-based treatments significantly.\nDavid Oswald, CEO of Branded Legacy, said; \"That the collaboration with Novus is a significant milestone in our mission to develop proprietary formularies tailored to both companies' needs and based on data identifying the most profitable products\".\nFrank Labrozzi, CEO of Novus, commented, \"The collaboration between health insuran...